Skip to main content
Scientific Reports logoLink to Scientific Reports
. 2023 Nov 17;13:20169. doi: 10.1038/s41598-023-46856-9

Publisher Correction: Bifurcation analysis of a tuberculosis progression model for drug target identification

Eliezer Flores-Garza 1, Rogelio Hernández-Pando 2, Ibrahim García-Zárate 3, Pablo Aguirre 4, Elisa Domínguez-Hüttinger 1,✉
PMCID: PMC10656549  PMID: 37978326

Correction to: Scientific Reports 10.1038/s41598-023-44569-7, published online 16 October 2023

The original version of this Article contained an error in Figure 3, where the labels on panels A, B and C were partly omitted. The original Figure 3 and accompanying legend appear below.

Figure 3.

Figure 3

Disease progression affects the sensitivity of the clinical phenotype to changes in the bifurcation parameters. (A) Bifurcation diagrams for the five bifurcation parameters across the 3 phases. Unstable solutions are not shown for clarity. Dotted vertical arrows denote threshold parameter values when an abrupt change in stability happens, from bacterial clearance to invasive infection or vice versa. (B) Right (P−) and left (P+) threshold parameter values enclosing the bistable region change as the disease progresses. Each row corresponds to one of the 5 bifurcation parameters, and the columns are the P− (left panel) P+ (right panel) threshold parameter values for each phase, normalized to its phase 1—specific threshold value. (C) Size of the bistable region. For negative P−, ΔP corresponds to P+.

The original Article has been corrected.


Articles from Scientific Reports are provided here courtesy of Nature Publishing Group

RESOURCES